Mark L. Berch

Array ( [id] => 4813963 [patent_doc_number] => 20080194594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Use of reversible inhibitors of s-adenosyl-l-homocysteine hydrolase for treating lupus' [patent_app_type] => utility [patent_app_number] => 11/894311 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17775 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194594.pdf [firstpage_image] =>[orig_patent_app_number] => 11894311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4688984 [patent_doc_number] => 20080033165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => '[Beta]-Lactamyl Vasopressin V1a Antagonists and Methods of Use' [patent_app_type] => utility [patent_app_number] => 11/835017 [patent_app_country] => US [patent_app_date] => 2007-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32046 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20080033165.pdf [firstpage_image] =>[orig_patent_app_number] => 11835017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4933518 [patent_doc_number] => 20080004293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'ADENOSINE RECEPTOR ANTAGONISTS AND METHODS OF MAKING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/829269 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18625 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20080004293.pdf [firstpage_image] =>[orig_patent_app_number] => 11829269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8630171 [patent_doc_number] => 08362244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Method for producing nucleoside derivatives' [patent_app_type] => utility [patent_app_number] => 11/782695 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5295 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11782695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265624 [patent_doc_number] => 20090118309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Selective antagonists of A2A adenosine receptors' [patent_app_type] => utility [patent_app_number] => 11/879133 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13963 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118309.pdf [firstpage_image] =>[orig_patent_app_number] => 11879133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977637 [patent_doc_number] => 08071565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Purine derivatives as a2a agonists' [patent_app_type] => utility [patent_app_number] => 12/308637 [patent_app_country] => US [patent_app_date] => 2007-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18726 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071565.pdf [firstpage_image] =>[orig_patent_app_number] => 12308637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016696 [patent_doc_number] => 20070259905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Camptothecin analogs and methods of preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/825729 [patent_app_country] => US [patent_app_date] => 2007-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16816 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259905.pdf [firstpage_image] =>[orig_patent_app_number] => 11825729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5029139 [patent_doc_number] => 20070270586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'NOVEL CRYSTAL OF 7-[2-[(2-AMINOTHIAZOL-4-YL)-2-HYDROXYIMINOACETAMIDE-3-VINYL-3-CEPHEM-4-CARBOXYLIC ACID (SYN ISOMER) AND METHOD FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 11/774035 [patent_app_country] => US [patent_app_date] => 2007-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6345 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270586.pdf [firstpage_image] =>[orig_patent_app_number] => 11774035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571946 [patent_doc_number] => 08338593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Modulators of toll-like receptor 7' [patent_app_type] => utility [patent_app_number] => 12/303214 [patent_app_country] => US [patent_app_date] => 2007-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61003 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12303214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899853 [patent_doc_number] => 20080119467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Purine Derivatives, Compositions Containing Them and Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/773572 [patent_app_country] => US [patent_app_date] => 2007-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5240 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119467.pdf [firstpage_image] =>[orig_patent_app_number] => 11773572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296315 [patent_doc_number] => 20100240623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => '8-OXOADENINE DERIVATIVES ACTING AS MODULATORS OF TLR7' [patent_app_type] => utility [patent_app_number] => 12/305801 [patent_app_country] => US [patent_app_date] => 2007-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18281 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240623.pdf [firstpage_image] =>[orig_patent_app_number] => 12305801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4827009 [patent_doc_number] => 20080125446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Purine analogs having HSP90-inhibiting activity' [patent_app_type] => utility [patent_app_number] => 11/772496 [patent_app_country] => US [patent_app_date] => 2007-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26827 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 46 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125446.pdf [firstpage_image] =>[orig_patent_app_number] => 11772496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797888 [patent_doc_number] => 20080009474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'PENEM PRODRUGS' [patent_app_type] => utility [patent_app_number] => 11/769849 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8205 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009474.pdf [firstpage_image] =>[orig_patent_app_number] => 11769849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4477535 [patent_doc_number] => 07906518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 11/823335 [patent_app_country] => US [patent_app_date] => 2007-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16157 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906518.pdf [firstpage_image] =>[orig_patent_app_number] => 11823335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670489 [patent_doc_number] => 20080045549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'ADENOSINE A2B RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/767575 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12708 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045549.pdf [firstpage_image] =>[orig_patent_app_number] => 11767575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4944579 [patent_doc_number] => 20080081906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-03 [patent_title] => ' CEFDINIR INTERMEDIATE' [patent_app_type] => utility [patent_app_number] => 11/766132 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5373 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20080081906.pdf [firstpage_image] =>[orig_patent_app_number] => 11766132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939604 [patent_doc_number] => 20080076923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Process for the preparation and purification of valgancyclovir' [patent_app_type] => utility [patent_app_number] => 11/820724 [patent_app_country] => US [patent_app_date] => 2007-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2798 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076923.pdf [firstpage_image] =>[orig_patent_app_number] => 11820724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853161 [patent_doc_number] => 20080318904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'DEUTERIUM-ENRICHED TENOFOVIR' [patent_app_type] => utility [patent_app_number] => 11/765677 [patent_app_country] => US [patent_app_date] => 2007-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3377 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318904.pdf [firstpage_image] =>[orig_patent_app_number] => 11765677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4461599 [patent_doc_number] => 07879998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => '4-alkenyl-2-azetidinone derivatives, process for preparing 4-alkenyl-2-azetidinone derivatives and multicyclic compounds prepared using 4-alkenyl-2-azetidinone derivatives' [patent_app_type] => utility [patent_app_number] => 11/765141 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7403 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879998.pdf [firstpage_image] =>[orig_patent_app_number] => 11765141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853177 [patent_doc_number] => 20080318920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'DEUTERIUM-ENRICHED EZETIMIBE' [patent_app_type] => utility [patent_app_number] => 11/765437 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3972 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318920.pdf [firstpage_image] =>[orig_patent_app_number] => 11765437 [rel_patent_id] =>[rel_patent_doc_number] =>)